VIRAL ANTIBODY-TITERS, IMMUNOGENETIC MARKERS, AND THEIR INTERRELATIONS IN MULTIPLE-SCLEROSIS PATIENTS AND CONTROLS

被引:9
作者
ALPEROVITCH, A
BERR, C
CAMBONTHOMSEN, A
PUEL, J
DUGOUJON, JM
RUIDAVETS, JB
CLANET, M
机构
[1] HOP PURPAN,INSERM,U100,TOULOUSE,FRANCE
[2] HOP PURPAN,VIROL LAB,TOULOUSE,FRANCE
[3] HOP PURPAN,CRPG,CNRS,UPR 8291,TOULOUSE,FRANCE
[4] HOP PURPAN,SERV NEUROL,TOULOUSE,FRANCE
关键词
D O I
10.1016/0198-8859(91)90011-W
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our purpose was to investigate possible interrelations between antibody titers against seven viruses (measles, rubella, herpes simplex, mumps, varicella-zoster, coronavirus, cytomegalovirus), HLA-class II antigens, and immunoglobulin Gm allotypes in multiple sclerosis (MS). We studied 57 MS patients and 59 controls with similar age and sex distributions. In MS patients, we found the classical increased frequency of HLA-DR2, HLA-DQw1 and also an excess of Gm (3; +/- 23; 5*). Mumps antibody levels were higher in MS patients than in controls; elevation was not significant for measles antibodies. Analysis suggests that an association between HLA-DQw1 and antibody titers against various viruses exists in controls but is absent in MS patients. In particular, we found that mumps antibody titers were higher in DQw1-positive than in DQw1-negative controls, while there was no significant difference among MS cases. Accordingly, we found that the overall difference between patients and controls was due to the fact that DQw1-positive patients had higher titers than controls, while DQw1-negative cases had similar titers as controls. These findings suggest that biological and molecular characteristics of DQw1 might differ in MS patients.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 25 条
[1]   GENETIC ASSOCIATION OF MULTIPLE-SCLEROSIS AND HL-A DETERMINANTS [J].
ALTER, M ;
HARSHE, M ;
ANDERSON, VE ;
EMME, L ;
YUNIS, EJ .
NEUROLOGY, 1976, 26 (01) :31-36
[2]   HISTOCOMPATIBILITY TYPES AND MEASLES ANTIBODIES IN MULTIPLE-SCLEROSIS AND OPTIC NEURITIS [J].
ARNASON, BGW ;
FULLER, TC ;
LEHRICH, JR ;
WRAY, SH .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1974, 22 (04) :419-428
[3]  
BENSSUSAN A, 1988, MED SCI, V12, P21
[4]   RISK-FACTORS IN MULTIPLE-SCLEROSIS - A POPULATION-BASED CASE-CONTROL STUDY IN HAUTES-PYRENEES, FRANCE [J].
BERR, C ;
PUEL, J ;
CLANET, M ;
RUIDAVETS, JB ;
MAS, JL ;
ALPEROVITCH, A .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (01) :46-50
[5]   IMMUNOGLOBULIN ALLOTYPES AND SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS - AN EPIDEMIOLOGIC AND GENETIC-STUDY IN THE HAUTES-PYRENEES COUNTY OF FRANCE [J].
BLANC, M ;
CLANET, M ;
BERR, C ;
DUGOUJON, JM ;
RUYDAVET, B ;
DUCOS, SJ ;
RASCOL, A ;
ALPEROVITCH, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1986, 75 (01) :1-5
[6]   BINDING OF LABELED INFLUENZA MATRIX PEPTIDE TO HLA DR IN LIVING B-LYMPHOID CELLS [J].
CEPPELLINI, R ;
FRUMENTO, G ;
FERRARA, GB ;
TOSI, R ;
CHERSI, A ;
PERNIS, B .
NATURE, 1989, 339 (6223) :392-394
[7]  
COHEN JHM, 1984, TISSUE ANTIGENS, V23, P156
[8]   VIRAL-INFECTION IN PATIENTS WITH MULTIPLE-SCLEROSIS AND HLA-DR MATCHED CONTROLS [J].
COMPSTON, DAS ;
VAKARELIS, BN ;
PAUL, E ;
MCDONALD, WI ;
BATCHELOR, JR ;
MIMS, CA .
BRAIN, 1986, 109 :325-344
[9]   INVITRO IMMUNE RESPONSIVENESS TO VACCINIA VIRUS AND HLA [J].
DEVRIES, RRP ;
KREEFTENBERG, HG ;
LOGGEN, HG ;
VANROOD, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (13) :692-696
[10]   RELATIONSHIPS BETWEEN 34 HLA-A, HLA-B AND HLA-DR ANTIGENS AND 3 SEROLOGICAL MARKERS OF VIRAL-INFECTIONS IN ALCOHOLIC CIRRHOSIS [J].
DOFFOEL, M ;
TONGIO, MM ;
GUT, JP ;
VENTRE, G ;
CHARRAULT, A ;
VETTER, D ;
LEDIG, M ;
NORTH, ML ;
MAYER, S ;
BOCKEL, R .
HEPATOLOGY, 1986, 6 (03) :457-463